Journal of Thrombosis and Thrombolysis
| 短名 | J Thromb Thrombolysis |
| Journal Impact | 2.24 |
| 国际分区 | PERIPHERAL VASCULAR DISEASE(Q2) |
| 期刊索引 | SCI Q2中科院 3 区 |
| ISSN | 0929-5305, 1573-742X |
| h-index | 81 |
| 国内分区 | 医学(3区)医学血液学(3区)医学心脏和心血管系统(4区)医学外周血管病(4区) |
《血栓和溶栓杂志》是当代心脏病学家、血液学家、血管医学专家和临床医生科学家期待已久的资源，这些专家积极参与涉及心血管和脑血管系统的血栓性疾病的治疗决策和临床研究。该杂志主要关注血栓形成和血管疾病的病理生物学，以及抗凝剂、血小板拮抗剂、细胞疗法和干预在科学研究、临床转化研究和患者护理中的应用。该杂志将发表原创作品，强调基础科学原理和临床研究之间的接口，促进血栓形成和血管科学的跨学科和学术对话。已发表的作品还将为转化研究、药物开发、临床试验和以患者为导向的应用定义平台。 JOURNAL OF THROMBOSIS AND THROMBOLYSIS”综合格式将扩展读者的知识库，并为医学血栓形成和血管科学中发展最快的领域的调查和直接临床应用提供重要的见解。
期刊主页投稿网址| 涉及主题 | 医学内科学心理学精神科生物外科心脏病学免疫学化学病理生物化学心肌梗塞血栓形成遗传学血液学物理重症监护医学血小板数学心房颤动 |
| 出版信息 | 出版商: Springer，出版周期: Bimonthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1994，原创研究文献占比: 85.27%，自引率:0.00%， Gold OA占比: 24.71% |
| 平均审稿周期 | 网友分享经验：偏慢,4-8周 |
| 平均录用比例 | 网友分享经验：容易 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Risk of incident venous thromboembolism in patients with atopic dermatitis: systematic analysis of the literature and meta-analysis
2024-9-6
Prognostic outcome of intravenous thrombolysis in elderly patients aged ≥ 60 years with acute ischemic stroke by ASTRAL and THRIVE scales
2024-9-6
Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital
2024-9-6
Heparin-like effect of a dual antiplatelet and anticoagulant (APAC) agent on red blood cell deformability and aggregation in an experimental model
2024-9-4
RNAi targeting LMAN1-MCFD2 complex promotes anticoagulation in mice
2024-9-2
E-Cigarettes induce expression of procoagulant tissue factor in cultivated human endothelial cells
2024-8-29
Finding individualised treatment in obese needing enoxaparin (FIT ONE): a multicentre study of therapeutic enoxaparin and the role of anti-factor Xa monitoring
2024-8-27
The potential role of factor XI inhibitors in managing long COVID
2024-8-26
Mortality rate and factors associated with in-hospital mortality in patients hospitalized with pulmonary embolism in Germany
2024-8-23
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management
2024-8-23
Intravenous thrombolysis versus dual antiplatelet therapy in minor ischemic stroke within the thrombolytic window (TAMIS): a multicenter cohort study
2024-8-23
Ghrelin may protect against vascular endothelial injury in Acute traumatic coagulopathy by mediating the RhoA/ROCK/MLC2 pathway
2024-8-23
COVID-19 vaccination and short-term anti-coagulation levels in warfarin treatment: correspondence
2024-8-16
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation
2024-8-14
Clot lysis time and thrombin generation in patients undergoing transcatheter aortic valve implantation
2024-8-8
Impact of thyroid function on coagulation and venous thromboembolism: a two-sample mendelian randomization study
2024-8-7
New interest in fibrinogen as an ischemic risk factor
2024-8-7
The use of non-vitamin K antagonist oral anticoagulants in chronic thromboembolic pulmonary hypertension: an updated meta-analysis
2024-7-30
Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis
2024-7-29
Factor XIa inhibition as a therapeutic strategy for atherothrombosis
2024-7-29
Comparative analysis of COVID-19-associated venous thromboembolism outcomes: evolution from 2020 to 2021–2022
2024-7-29
Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study
2024-7-28
Machine learning-based prediction model of lower extremity deep vein thrombosis after stroke
2024-7-27
Enhanced thrombin generation induced by extracellular vesicles from severe COVID−19 cases
2024-7-27
Identifying the vulnerable patient: pericoronary Adipose tissue attenuation on computed tomography
2024-7-16
Risks of major bleeding and venous thromboembolism in patients undergoing total hip or total knee arthroplasty using therapeutic dosages of DOACs
2024-7-16
The journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting
2024-7-9
Accuracy of the COMPASS-CAT thrombosis risk assessment scale in predicting venous thromboembolism in cancer patients: a meta-analysis
2024-7-9
Risk of venous thromboembolism in relation to high physical activity level in men over 27 year follow up
2024-7-9
Clinical outcomes of patients with atrial fibrillation in relation to multimorbidity status changes over time and the impact of ABC pathway compliance: a nationwide cohort study
2024-7-9
Initial hemodynamic status and Acute Mortality in Cancer patients with Acute Pulmonary Embolism: from the COMMAND VTE Registry
2024-7-9
SARS-CoV-2 spike protein potentiates platelet aggregation via upregulating integrin αIIbβ3 outside-in signaling pathway
2024-7-9
Reduced protein carbonylation on hormone therapy is associated with improved fibrinolysis in postmenopausal women: the impact of PAI-1 and TAFI activity
2024-7-9
Elevated plasma protein carbonylation increases the risk of ischemic cerebrovascular events in patients with atrial fibrillation: association with a prothrombotic state
2024-7-4
Assessment of associations between neutrophil extracellular trap biomarkers in blood and thrombi in acute ischemic stroke patients
2024-6-9
Effect of Ultrasound on Thrombus debris during Sonothrombolysis in a Microfluidic device
2024-6-2
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study
2024-6-2
ET1 acts as a potential plasma biomarker and therapeutic target in deep venous thrombosis rat model
2024-6-2
Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis
2024-5-24
Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial
2024-5-18
Factor XI as a new target for prevention of thromboembolism in cardiovascular disease: a meta-analysis of randomized controlled trials
2024-5-18
NEUT-RI, a surrogate marker of NETosis is lower in patients with strong IgM antiphospholipid antibodies
2024-5-18
Optimizing resource allocation: Cost-effectiveness of specified D-dimer cut-offs in cancer patients with suspected venous thromboembolism
2024-5-18
Optimal hemodynamic parameters for risk stratification in acute pulmonary embolism patients
2024-5-18
Patent foramen ovale closure in ischemic stroke patients with and without thrombophilia: a systematic review and meta-analyses
2024-5-18
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2
2024-5-18
Cancer progression and tumor hypercoagulability: a platelet perspective
2024-5-17
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study
2024-5-12
Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review
2024-5-11
Dual Antiplatelet Therapy vs Alteplase in Adult Patients with Acute Minor Ischemic Stroke: A Systematic Review and Meta-Analysis
2024-5-9
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远